Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing

Cancer Research

Volumn 57, Issue 4, 1997, Pages 759-764

  Ji, Hongjun ^b   Liu, Yiliang E ^a   Jia, Tongli ^a   Wang, Mingsheng ^a   Liu, Jingwen ^c   Xiao, Guowei ^a   Joseph, Benjamin K ^a   Rosen, Craig ^b   Shi, Y Eric ^a,d  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^b GLAXOSMITHKLINE   (United States)

^c Boise VA Medical Center   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; TUMOR MARKER;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ARTICLE; BREAST CANCER; COMPLEMENT ACTIVATION; DNA LIBRARY; DNA SEQUENCE; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME;

AMINO ACID SEQUENCE; BREAST NEOPLASMS; CONSERVED SEQUENCE; FEMALE; GAMMA-SYNUCLEIN; GENETIC MARKERS; HUMANS; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; NERVE TISSUE PROTEINS; ONCOGENES; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA;

EID: 0031045589     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Porler-Jordan, K., and Lippman, M. E. Overview of the biological markers of breast cancer. Hematol. Oncol. Clin. North Am., 8: 73-100, 1994.
2. Manning, D. L., McClelland, R. A. Knowlden, J. M., Bryam, S., Green, C. D., Sutherland, R. L., and Ormandy, C. J. Differential expression of oestrogen regulated genes in breast cancer. Acta Oncol., 34: 641-646, 1995,
3. Watson, M- A., and Fleming, T. P. Isolation of differentially expressed sequence tags from human breast cancer Cancer. Res., 54: 4598-4602, 1994.
4. Sager, R., Anisowicz, A., Neveu, M., Liang, P., and Soliropoulou, G. identification by differential display of α6 integrin as a candidate tumor suppressor gene. FASEB J., 7: 964-970, 1993.
5. Chen, Z., and Sager, R. Differential expression of human tissue factor in normal mammary epithelial cells and in carcinomas. Mol. Med., 1: 153-160, 1995.
6. Zhang, M., Zou, Z., Maass, N., and Sager, R. Differential expression of elafin in human normal mammary epithelial cells and carcinomas is regulated at the transcriptional level. Cancer Res., 55: 2537-2541, 1995.
7. Zou, Z., Anisowicz, A., Hendrix, M. J., Thor, A., Neveu, M., Sheng, S., Rafidi, K., Seftor, E., and Sager, R. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science (Washington DC), 263: 526-529.
8. Liang, P., Averboukh, L., Keyomarsi, K., Sager, R., and Pardee, A. B. Differential display and cloning of messenger RNAs from human breast cancer versus mammary epithelial cells. Cancer Res., 52: 6966-6968, 1992.
9. Adams, M. D., Soares, M. B., Kerlavage, A. R., Field, C., and Venter, J. C. Rapid cDNA sequencing (expressed sequence tags) from a directionally cloned human infant brain cDNA library. Nat. Genet., 4: 373-380, 1993,
10. Adams, M. D., Kelley, J. M., Gocayne, J. D., Dubnick, M., Polymeropoulos, M. H., Xiao, H., Merril, C. R., Wu, A., Oide, B., Moreno, R. F., Kerlavage, A. R., McCombie, W. R., and Venter, J. C. Complementary DNA sequencing; expressed sequence tags and human genome project. Science (Washington DC), 252: 1651-1656, 1991.
11. Velculescu, V. E., Zhang, L., Vogelstein, B., and Kinzler, K. W. Serial analysis of gene expression. Science (Washington DC), 270: 484-487, 1995.
12. Schena, M., Shalon, D., Davis, R. W., and Brown, P. O. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science (Washington DC), 270: 467-470, 1995.
13. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroforrn extraction. Anal. Biochem., 762: 156-159, 1987.
14. Angerer, M. L., and Angerer, R. C. In situ hybridization to cellular RNA. In: D. Rickwood and B. D. Hames (eds.), In Situ Hybridization, pp. 15-32. London: LRL Press, 1992.
15. Rochefort, H., Capony, F., Garcia, M., Cavailles, V., Freiss, G., Chambon, M., Morisset, M., and Vignon, F. Estrogen-induced lysosomal proteases secreted by breast cancer cells: a role in carcinogenesis? J. Cell. Biochem., 35: 17-29, 1987.
16. Cavaiiles, V., Augereau, P., and Rochefort, H. Cathepsin D gene of human MCF-7 cells contains estrogen-responsive sequences on its 5′ proximal flanking region, Biochem. Biophys. Res. Commun., 174: 816-824, 1991.
17. Capony, F., Rougeot, C., Cavailles, V., and Rochefort, F. Estradiol increases the secretion by MCF-7 cells of several lysosomal pro-enzymes. Biochem. Biophys. Res. Commun., 171: 972-978, 1990.
18. Brouillet, J. P., Theillet, C., Maudelonde, T., Defrenne, A., Simony-Lafontaine, J., Sertour, J., Pujol, H., Jeanteur, P., and Rochefort, H. Cathepsin D assay in primary breast cancer and lymph nodes: relationship with c-myc, c-erb-B-2 oncogene amplification and node invasiveness. Eur. J. Cancer, 26: 437-441, 1990.
19. Spyratos, F., Maudelonde, T., Brouillet, J. P., Brunei, M., Defrenne, A., Andrieu, C., Hacene, K., Desplaces, A., Rouesse, J., and Rochefort, H. Cathepsin D, an independent prognostic factor for metastasis of breast cancer. Lancet, 11: 1115-1118, 1989.
20. Rochefort, H., Cavailles, V., Augereau, P., Capony, F., Maudelonde, T., Touitou, I., and Garcia, M. Overexpression and hormonal regulation of pro-cathepsin D in mammary and endometrial cancer, J. Steroid Biochem., 34: 177-182, 1989.
21. Foekens, J. A., Look, M. P., Peters, H. A., Van Putten, W. L., Portengen, H., and Klijn, J. G. Urokinase-type plasminogen activator and its inhibitor PAI-1: predictor of poor response to tamoxifen therapy in recurrent breast cancer. J. Natl. Cancer Inst., 57: 751-756, 1995.
22. Koran-Hand, P., Colcher, D., Salomon, D., Ridge, J., Noguchi, P., and Schlom, J. Influence of spatial configuration of carcinoma cell populations on the expression of a tumor-associated glycoprotein. Cancer Res., 45: 833-840, 1986.
23. Hunt, G. The role of laminin in cancer invasion and metastasis. Exp. Cell Biol., 57: 165-176, 1989.
24. Castronovo, V., Colin, C., Claysmith, A. P., Chen, P. H., Lifrange, E., Lambotte, R., Krutzsch, H., Liotta, L. A., and Sobel, M. E. Immunodetection of the metastasis-associated laminin receptor in human breast cancer cells obtained by fine-needle aspiration biopsy. Am. J. Pathol., 137: 1373-1381, 1990.
25. Marques, L. A., Franco, E. L., Torloni, H., Brentani, M. M., da Silva-Neto, J. B., and Brentani, R. R. Independent prognostic value of laminin receptor expression in breast cancer survival. Cancer Res., 50: 1479-1483, 1990.
26. Gasparini, G., Barbareschi, M., Boracchi, P., Bevilacqua, P., Verderio, P., DallaPalma, P., and Menard, S. 67 kDa laminin-receptor expression adds prognostic information to intra-tumoral microvessel density in node-negative breast cancer. Int. J. Cancer., 60: 604-610, 1995.
27. Altschul, S. F., Gish, W., Miller, W., Myers, E. W., and Lipman, D. J. Basic local alignment search tool. J. Mol. Biol., 275: 403-410, 1990.
28. Ueda, K., Fukushima, H., Mas]iah, E., Xta, Y., Iwai, A, Yoshimolo, M., Otero, D. A., Kondo, J., Ihara, Y., and Saitoh, T. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzhetmcr disease. Proc. Natl. Acad. Sci. USA, 90: 11282-11286, 1993.
29. Goldhirsch, A. Meeting highlights (St. Gallen 1995): International Consensus Panel on the Treatment of Primary Breast Cancer (Commentary). J. Nail. Cancer Inst., 97: 1141-1145, 1995.
30. Ernster, V. L. Barclay, J., Kerlikowske, K., Grady, D., and Henderson, C. Incidence of and treatment for ductal carcinoma in situ of the breast. J. Am. Med. Assoc., 275: 913-918, 1996.
31. Allred, D. C., Clark, G. M., Tandon, A. K., Molina, R., Tofiney, D. C., Osborne, C. K., Gilchrist, K. W., Mansour, E. G., Abeloff, M., and Eudey, L. Her-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma. J. Clin. Oncol, 10: 599-605, 1992.
32. Gusterson, B. A., Gelber, R. D., Goldhirsch, A., Price, K. N., Soderborgh, J., Anbazhagan, R., Styles, J., Rudenstam, C. M., Golouh, R., and Reed, R. Prognostic importance of c-erbB-2 expression in breast cancer. J. Clin. Oncol., 10: 1049-1056, 1992.
33. Bergh, J., Norberg, T., Sjogren, S., Lindgren, A., and Holmberg, L. Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy. Nat. Med., 10: 1029-1034, 1995.
34. Elledge, R. M., Fuqua, S. A., Clark, G. M., Pujol, P., and Allred, D. C. The role and prognostic significance of p53 gene alterations in breast cancer. Breast Cancer Res. Treat., 27: 95-102, 1993,
35. Steeg, P. S., De La Rosa, A., Flatow, U., MacDonald, N. J., Benedict M, and Leone A. Nm23 and breast cancer metastasis. Breast Cancer Res. Treat., 25: 175-187, 1993.
36. Ferno, M., Baldetorp, B., Borg, A., Brouillet, J. P., Olsson, H., Rochefort, H., Seilberg, G., Sigurdsson, H., and Killander, D. Cathepsin D, both a prognostic factor and a predictive factor for the effect of adjuvant tamoxifen in breast cancer: South Sweden Breast Cancer Group. Eur. J. Cancer, 30A: 2042-2048, 1994,
37. Kiijn, J. G. M., Berns, E. M. J. J., and Foekens, J. A. Prognostic factors and response to therapy in breast cancer. Cancer Surv. 18: 165-198, 1993.
38. Harris, A. L., Fox, S., Leek, R., Zhang, H., Scott, P., Bicknell, R., and Gatter, K. Breast cancer angiogenesis: therapy target and prognostic factor. Eur. J. Cancer, 31A: 831-832, 1995.
39. Gasparini, G., Pozza, F., and Hariss, A. L. Evaluating the potential usefulness of new prognostic and predictive indicators in node-negative breast cancer patients. J. Natl. Cancer Inst., 55: 1206-1219, 1993. (Erratum, J. Natl. Cancer Insl., 85: 1605, 1993).
40. Miki, Y., Swenson, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M. Ding, W., Bell, R., Rosenthal, J. Hussey, C., Tran, T., McClure, M., Frye, C., Hattier, T., Phelps, R., Haugen-Strano, A., Katcher, H., Yakumo, K., Gholami, Z., Shaffer, D., Stone, S., Bayer, S., Wray, C., Bogden, R., Dayananth, P., Ward, J., Tonin, P., Narod, S., Bristow, P. K., Norris, F. H., Helvering, L., Morrison, P., Rosteck, P., Lai, M., Barrett, J. C., Lewis, C., Neuhausen, S., Cannon-Albright, L., Goldgar, D., Wiseman, R., Kamb, A., and Skolnick, M. H. A strong candidate for the breast and ovarian cancer susceptibility gene BRCAI. Science (Washington DC), 266: 66-71, 1994.
41. Wooster, R., Neuhausen, S. L., Mangion, J., Quirk, Y., Ford, D., Collins, N., Nguyen, K., Seal, S., Tran, T., and Averill, D. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science (Washington DC), 265: 20882090, 1994.
42. Futreal, P. A., Liu, Q., and Shattuck-Eidens, D. BRCA1 mutations in primary breast and ovarian carcinomas. Science (Washington DC), 266: 120-122, 1994.
43. Ozzello, L. Intraepithelial carcinoma of the breast. In: K. H. Hollman and J. M. Verley (eds.), New Frontiers in Mammary Pathology. New York: Plenum Publishing Corp., 1983.
44. Barsky, S. H., Siegal, G. P., Jannotta, F., and Liotta, L. A. Loss of basement membrane components by invasive tumors but not by their benign counterparts. Lab. Invest., 49: 140-147, 1983.
45. Brown, P. W., Silverman, J., Owens, E., Tabor, D. C., Terz, J. J., and Lawrence, W., Jr. Intraductal "non-filtrating" carcinoma of the breast. Arch. Surg., 111: 1063-1067, 1976.
46. Lagios, M. D. Carcinoma in situ: pathology and treatment. Surg. Clin. North Am., 70: 853-871, 1990.
47. Masters, C- L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., and Beyreuther, K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. USA, 82: 4245-4249, 1985.
48. Mattson, M. P., Rydel, R. E., Lieberburg, I., and Smith-Swimosky, V. L. Altered calcium signaling and neuronal injury: stroke and Alzheimer's disease as example. Ann, NY Acad. Sci., 679: 1-21, 1993.
49. Barger, S. W., Fiscus, R. P., Ruth, P., Hofmann, F., and Mattson, M. P. Role of cyclic GMP in the regulation of neuronal calcium and survival by secreted forms of β-amyloid precursor. J. Neurochem., 64: 2087-2096, 1995.